Oral Dexamethasone to Control Wheezing in Children at an Outpatient Clinic
| Autor: | Brittany S. Richardson, Neel Mahesh Naik, Heidi Schwarzwald, Stephanie Marton, Luis Rauda, Angela S. Volk |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Medical home medicine.medical_specialty medicine.drug_class Prednisolone Administration Oral Ambulatory Care Facilities Dexamethasone Oral dexamethasone 03 medical and health sciences 0302 clinical medicine Recurrence 030225 pediatrics medicine Humans Outpatient clinic Child Glucocorticoids Respiratory Sounds Retrospective Studies Asthma business.industry Childhood disease Emergency department medicine.disease Hospitalization Treatment Outcome Acute Disease Pediatrics Perinatology and Child Health Emergency medicine Corticosteroid Female business Follow-Up Studies medicine.drug |
| Zdroj: | Clinical Pediatrics. 58:151-158 |
| ISSN: | 1938-2707 0009-9228 |
| DOI: | 10.1177/0009922818809466 |
| Popis: | Asthma, a chronic childhood disease, has resulted in increased emergency department (ED) visits with high costs. Many asthma ED visits are nonemergent and could be treated in outpatient clinics. Literature has concluded that a 2-day course of oral dexamethasone has comparable outcomes to a 5-day course of prednisone in the ED and hospital setting. A retrospective chart review was performed on children requiring in-house treatment with a corticosteroid (dexamethasone n = 23, prednisone n = 40) for acute asthma exacerbations at an ambulatory medical home. The rates of hospital admissions, ED visits, and symptom follow-up were similar between the 2 groups ( P > .05). The cost for a course of dexamethasone was US$1.28 versus US$16.20 for prednisolone. The average cost for an asthma exacerbation office visit was US$79.89 compared with US$3113.28 for an ED visit. A 2-day course of oral dexamethasone appears to be a promising clinical and cost-effective treatment for acute asthma exacerbations at the primary care level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|